Bad RSV season leaves babies at risk amid antibody shortage
Despite FDA approval, the new RSV antibody, Beyfortus, is in short supply, leaving many infants susceptible to severe respiratory infections.
Source: dailyprogress.com
Kate Cramer Bour News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kate Cramer Bour. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Kate Cramer Bour Today - Breaking & Trending Today
A new immunization hinted at an end to bad RSV seasons. But an ongoing shortage means babies are still getting sick
As a pulmonary critical care specialist, Dr. Cassondra Cramer-Bour knows intimately what RSV, or respiratory syncytial virus, can do to a person’s lungs.
Source: cnn.com
Ongoing RSV vaccine shortage means babies are still getting sick
Parents have been eagerly awaiting the new immunization, which clinical trials found to be 75% effective at preventing RSV infections severe enough to be seen by a doctor.
Source: mynbc5.com
Bad RSV season leaves babies at risk amid antibody shortage
Despite FDA approval, the new RSV antibody, Beyfortus, is in short supply, leaving many infants susceptible to severe respiratory infections.
Source: tdn.com
A new immunization hinted at an end to bad RSV seasons. But an ongoing shortage means babies are still getting sick
(CNN) — As a pulmonary critical care specialist, Dr. Cassondra Cramer-Bour knows intimately what RSV, or respiratory syncytial virus, can do to a person’s lungs.
Source: kdrv.com